Migraine Care

Capture preventive medication adherence during recall calls for migraine patients

AI-powered recall intake for established migraine patients asks about current preventive medication use, breakthrough migraine frequency since last visit, and medication side effects, then routes outcomes to clinical staff for follow-up scheduling.

How it pays back

Preventive Therapy Gaps Caught Before They Escalate

Patient tells AI they stopped their preventive because of side effects or cost. That signal reaches your clinical team immediately for outreach, not three months later when the patient comes in with status migrainosus.

Adherence Data Informs Clinical Decisions

Structured recall intake shows which patients are stable on current therapy, which are having breakthrough migraines despite compliance, and which have abandoned therapy. Your team can prioritize interventions.

Reduce No-Show and Missed Follow-Up for Chronic Migraine

AI calls to confirm adherence and invite follow-up. Patients who need visit scheduling are connected to booking; those stable on therapy confirm no-visit-needed status. Appointment slots fill with patients who genuinely need them.

Recall Intake Data Surfaces Panel Patterns

Over time, recall intake data shows your panel's preventive therapy patterns, most common side effects, and medication trial outcomes—actionable intelligence for clinical protocol refinement.

Adherence status captured

On schedule, missed doses, stopped, or side effect-related discontinuation documented on recall call

Breakthrough migraine frequency tracked

Patient-reported attack frequency since last visit compared to baseline

Urgent callback flagged

Patients with increased migraine days or medication discontinuation routed to clinical queue

Appointment slots optimized

Recall intake routes stable patients to phone follow-up and at-risk patients to scheduled visits

Frequently asked questions

What if a recall patient says they stopped their preventive medication?

The AI captures why: side effects, cost, lack of perceived benefit, or other barriers. That response is flagged in the summary and routed to your clinical team for nurse callback or provider outreach. Your team can address the barrier—adjust the dose, switch to a better-tolerated agent, or discuss coverage options.

Can the AI make refill authorizations based on recall responses?

The AI captures the patient's current therapy status and refill need as a structured summary for your provider or nurse. If the patient is stable on their current preventive and reports good adherence, your clinical team reviews that data for one-click refill authorization. The AI does not authorize—it surfaces the data for clinical approval.

How do I know if a patient actually needs an in-person visit vs. phone follow-up?

Your protocol defines the criteria. For example: patients with stable migraine frequency and no new symptoms get phone or telehealth follow-up; patients with increased frequency, new neurological symptoms, or medication failure get scheduled in-person visits. The AI route and booking system applies your rules.

What if a recall patient reports new severe migraine?

The AI captures the reported severity and symptom pattern. If it matches your urgent criteria (new onset, sudden severe, or refractory symptoms), the call is escalated to the provider or on-call line immediately. Recall call becomes urgent triage.

Can the AI track which preventive medications are working best in my patient population?

Yes. Over time, recall data shows medication adherence patterns, reported outcomes (breakthrough migraine frequency on therapy), and side effect profiles. Your clinical team can review this data to inform prescribing patterns and protocol refinements.

Related reading

Bring this to your practice

See how MedReception AI handles after-hours calls, scheduling, intake, and patient communication for medical practices like yours.

Want the numbers first? See plans and pricing

AI Reception for Migraine Patient Recall and Preventive Adherence Intake | Medreception AI